Humacyte, Inc., is a medical research, discovery and development company with clinical and pre-clinical stage investigational products primarily focused on developing a proprietary novel technology based on human tissue-based products for key applications in regenerative medicine and vascular surgery: engineered human collagen-based products The company uses its innovative, proprietary platform technology to engineer human, extracellular matrix-based tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues. These are being developed for potential use in many specific applications, with the goal to significantly improve treatment outcomes for many patients, including those with vascular disease and those requiring hemodialysis. The company's proprietary technologies are designed to create off-the-shelf products that, once approved, can be utilized in any patient.
